Leading pharmaceutical innovation in neurological care with our comprehensive Gabaxone range. From neuropathic pain management to epilepsy treatment, our gabapentin-based formulations provide healthcare professionals with trusted therapeutic solutions for optimal patient outcomes.
Our comprehensive Gabaxone portfolio offers healthcare professionals multiple formulation options to address various neurological conditions with precision and efficacy.
Primary anticonvulsant medication for initial management of epilepsy and neuropathic pain conditions. Ideal for patients requiring lower dosage initiation and dose titration.
Standard strength formulation for comprehensive management of moderate to severe neuropathic pain and epileptic conditions. Enhanced efficacy for established treatment protocols.
Synergistic combination therapy providing neuroprotection and pain relief. Methylcobalamin enhances nerve regeneration while gabapentin manages pain symptoms.
High-potency combination for severe neuropathic pain conditions. Optimized dosing for maximum therapeutic benefit with enhanced nerve health support.
Dual-mechanism combination for refractory neuropathic pain. Combines gabapentin's anticonvulsant properties with nortriptyline's antidepressant and analgesic effects.
Advanced neurological therapeutic solution designed for specific patient populations requiring specialized care and targeted intervention.
Our Gabaxone range provides comprehensive therapeutic solutions for a wide spectrum of neurological conditions, backed by clinical evidence and proven efficacy.
Gabaxone provides effective adjunctive therapy for partial seizures and generalized tonic-clonic seizures. Our formulations help reduce seizure frequency and improve quality of life through precise dose optimization and excellent tolerability profiles.
Our gabapentin-based formulations excel in treating diabetic peripheral neuropathy, post-herpetic neuralgia, and complex regional pain syndrome. Combination products with methylcobalamin offer enhanced neuroprotection and nerve regeneration support.
Gabaxone demonstrates significant efficacy in migraine prophylaxis, reducing frequency and severity of migraine episodes. Particularly effective for patients with comorbid anxiety or those requiring alternative preventive approaches.
Our specialized combinations address the complex nature of fibromyalgia, providing relief from widespread musculoskeletal pain, sleep disturbances, and associated fatigue through targeted neurochemical modulation.
Hitzelberger Life Sciences combines cutting-edge manufacturing with rigorous quality control to deliver pharmaceutical excellence in every Gabaxone product.
Our state-of-the-art facilities ensure consistent bioavailability, optimal stability, and superior therapeutic outcomes. Every Gabaxone product undergoes stringent quality testing and adheres to international pharmaceutical standards, providing healthcare professionals with reliable and effective neurological treatments.
Optimized bioavailability and enhanced stability profiles
WHO-GMP compliant manufacturing and testing protocols
Robust clinical data supporting efficacy and safety
Comprehensive medical information and support services
At Hitzelberger Life Sciences, we are dedicated to advancing neurological therapeutics through innovative formulations and unwavering commitment to quality. Our Gabaxone range represents years of pharmaceutical expertise, combining proven active ingredients with advanced delivery systems to optimize patient outcomes. We partner with healthcare professionals to ensure every patient receives the most appropriate and effective neurological care available.